These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 32242499)

  • 1. Computational elucidation and validation of the three-dimensional structure of humanized aldolase catalytic antibody 38C2.
    Jayakody RS; Jasin Arachchige LI; Japahuge A
    J Biomol Struct Dyn; 2021 Apr; 39(7):2463-2477. PubMed ID: 32242499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A humanized aldolase antibody for selective chemotherapy and adaptor immunotherapy.
    Rader C; Turner JM; Heine A; Shabat D; Sinha SC; Wilson IA; Lerner RA; Barbas CF
    J Mol Biol; 2003 Sep; 332(4):889-99. PubMed ID: 12972259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enantioselective aldol cyclodehydrations catalyzed by antibody 38C2.
    List B; Lerner RA; Barbas CF
    Org Lett; 1999 Jul; 1(1):59-61. PubMed ID: 10822533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing the synthetic utility of aldolase antibody 38C2.
    Mondal K; Ramesh NG; Roy I; Gupta MN
    Bioorg Med Chem Lett; 2006 Feb; 16(4):807-10. PubMed ID: 16321532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of aldolase antibodies in vitro: correlation of catalytic activity and reaction-based selection.
    Tanaka F; Fuller R; Shim H; Lerner RA; Barbas CF
    J Mol Biol; 2004 Jan; 335(4):1007-18. PubMed ID: 14698295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of integrin alpha(v)beta3-targeting Ab 38C2 constructs.
    Sinha SC; Das S; Li LS; Lerner RA; Barbas CF
    Nat Protoc; 2007; 2(2):449-56. PubMed ID: 17406606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cofactor approach to copper-dependent catalytic antibodies.
    Nicholas KM; Wentworth P; Harwig CW; Wentworth AD; Shafton A; Janda KD
    Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2648-53. PubMed ID: 11880619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo activity in a catalytic antibody-prodrug system: Antibody catalyzed etoposide prodrug activation for selective chemotherapy.
    Shabat D; Lode HN; Pertl U; Reisfeld RA; Rader C; Lerner RA; Barbas CF
    Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7528-33. PubMed ID: 11404472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldol sensors for the rapid generation of tunable fluorescence by antibody catalysis.
    List B; Barbas CF; Lerner RA
    Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15351-5. PubMed ID: 9860972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An efficient benchtop system for multigram-scale kinetic resolutions using aldolase antibodies.
    Turner JM; Bui T; Lerner RA; Barbas CF; List B
    Chemistry; 2000 Aug; 6(15):2772-4. PubMed ID: 10985725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of an organoinsulin molecule that can be activated by antibody catalysis.
    Worrall DS; McDunn JE; List B; Reichart D; Hevener A; Gustafson T; Barbas CF; Lerner RA; Olefsky JM
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13514-8. PubMed ID: 11707596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-lactam-based approach for the chemical programming of aldolase antibody 38C2.
    Gavrilyuk JI; Wuellner U; Barbas CF
    Bioorg Med Chem Lett; 2009 Mar; 19(5):1421-4. PubMed ID: 19181522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple catalytic aldolase antibodies suitable for chemical programming.
    Goswami RK; Huang ZZ; Forsyth JS; Felding-Habermann B; Sinha SC
    Bioorg Med Chem Lett; 2009 Jul; 19(14):3821-4. PubMed ID: 19428247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visualizing antibody-catalyzed retro-aldol-retro-Michael reactions.
    Tanaka F; Kerwin L; Kubitz D; Lerner RA; Barbas CF
    Bioorg Med Chem Lett; 2001 Nov; 11(22):2983-6. PubMed ID: 11677141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small molecule drug activity in melanoma models may be dramatically enhanced with an antibody effector.
    Popkov M; Rader C; Gonzalez B; Sinha SC; Barbas CF
    Int J Cancer; 2006 Sep; 119(5):1194-207. PubMed ID: 16570283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly efficient antibody-catalyzed deuteration of carbonyl compounds.
    Shulman A; Sitry D; Shulman H; Keinan E
    Chemistry; 2002 Jan; 8(1):229-39. PubMed ID: 11822454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-catalyzed benzoin oxidation as a mechanistic probe for nucleophilic catalysis by an active site lysine.
    Sklute G; Oizerowich R; Shulman H; Keinan E
    Chemistry; 2004 May; 10(9):2159-65. PubMed ID: 15112204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reaction properties of catalytic antibodies encapsulated in organo substituted SiO2 sol-gel materials.
    Kato K; Saito T; Seelan S; Tomita M; Yokogawa Y
    J Biosci Bioeng; 2005 Oct; 100(4):478-80. PubMed ID: 16310742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substrate-selective mechanisms in biocatalysis demonstrated with a versatile and efficient aldolase antibody.
    Shulman H; Keinan E
    Bioorg Med Chem Lett; 1999 Jul; 9(13):1745-50. PubMed ID: 10406635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amperometric assay for aldolase activity: antibody-catalyzed ferrocenylamine formation.
    Sagi A; Rishpon J; Shabat D
    Anal Chem; 2006 Mar; 78(5):1459-61. PubMed ID: 16503594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.